Publikation

Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE.

Wissenschaftlicher Artikel/Review - 01.05.2024

Bereiche
PubMed
DOI
Kontakt

Zitation
Chen C, Shoamanesh A, Colorado P, Saad F, Lemmens R, De Marchis G, Caso V, Xu L, Heenan L, Masjuan J, Christensen H, Connolly S, Khatri P, Mundl H, Hart R, Smith E. Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE. Stroke 2024
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Stroke 2024
Veröffentlichungsdatum
01.05.2024
eISSN (Online)
1524-4628
Kurzbeschreibung/Zielsetzung

In the phase 2 PACIFIC-STROKE trial (Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following Acute Noncardioembolic Stroke), asundexian, an oral factor XIa inhibitor, did not increase the risk of hemorrhagic transformation (HT). In this secondary analysis, we aimed to investigate the frequency, types, and risk factors of HT on brain magnetic resonance imaging (MRI).